| Literature DB >> 26311603 |
Pratima Sharma1, Khurram Bari2.
Abstract
Liver transplantation is the standard of care for patients with decompensated cirrhosis. Liver transplantation recipients have excellent short-term and long-term outcomes including patient and graft survival. Since the adoption of model for end-stage liver disease (MELD)-based allocation policy, the incidence of post-transplant end stage renal disease has risen significantly. Occurrence of Stage 4 chronic kidney disease and end stage renal disease substantially increases the risk of post-transplant deaths. Because majority of late post-transplant mortality is due to nonhepatic post-transplant comorbidities, personalized care directed toward risk factor modification may further improve post-transplant survival.Entities:
Keywords: Chronic kidney disease; ESRD; Liver transplantation; MELD
Mesh:
Year: 2015 PMID: 26311603 PMCID: PMC4556126 DOI: 10.1053/j.ackd.2015.06.001
Source DB: PubMed Journal: Adv Chronic Kidney Dis ISSN: 1548-5595 Impact factor: 3.620